Widely considered to be an expert in health and wellness, Daschle’s appointment could be a boon for Northern Swan’s ongoing expansion efforts in the global medical cannabis market. Last month, Northern Swan generated headlines after announcing it had closed $58 million in Series D financing, raising its total capital to date to $96 million. In 1986, he was elected to the U.S. Senate and was chosen as Senate Democratic Leader in 1994. Iris Dorbian: What made you decide to join the board of Northern Swan Holdings? Tom Daschle: Northern Swan has an exciting and ambitious plan to cultivate high quality cannabis and deliver it in health and wellness products around the globe.

Source: Forbes May 24, 2019 19:52 UTC